Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours without surgery
Mortality from gastric cancer is the second highest of all cancers within Japan, and the increasing age and weight of the Japanese population makes surgery to treat this cancer progressively more difficult. Dr Takeshi Sano discusses D2 lymphadenectomy, a lymph node dissection procedure that has been developed in Japan for the treatment of gastric cancer and suggests reasons for the high level of geographic homogeneity seen in global gastric cancer treatment outcomes.
This programme was supported by BAYER.
Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours without surgery
SIOG 2024: Updates in medical oncology
Robotic surgery for older patients with colorectal cancer shows positive outcomes
Post-diagnosis diet, nutrition and cancer prognosis
Laser oncosurgery - A new perspective in treating cancer
WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India
ESMO 2024: Highlights and analysis
Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery
The parotid gland; an unusual site of colorectal cancer metastasis